Close this search box.

George Eliades at the helm of Mythic

ARTICLE | Management Tracks

Plus: Michael Lenardo to become CSO at Calico, and updates from Aveo and Dyadic

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst  

March 28, 2024 11:53 PM UTC

Antibody-drug conjugate company Mythic Therapeutics Inc. named George Eliades president and CEO. Eliades was SVP of corporate development and chief transformation officer at Jazz Pharmaceuticals plc (NASDAQ:JAZZ).

Michael Lenardo will become CSO of Calico Life Sciences LLC in August. Lenardo is co-director of the NIH’s National Institute of Allergy and Infectious Diseases Clinical Genomics Program…